The Chinese medicine Kuan-Sin-Yin improves liver function in patients with chronic hepatitis C: A randomised and placebo-controlled trial-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The Chinese medicine Kuan-Sin-Yin improves liver function in patients with chronic hepatitis C: A randomised and placebo-controlled trial

Published:2016-08 Issue: Volume:27 Page:114-122
ISSN:0965-2299
Container-title:Complementary Therapies in Medicine
language:en
Short-container-title:Complementary Therapies in Medicine

Author:

Liu Chia-Yu,Ko Pin-Hao,Yen Hung-Rong,Cheng Chen-Hung,Li Yu-Hsien,Liao Zih-Han,Hsu Chung-Hua

Publisher

Elsevier BV

Subject

Advanced and Specialised Nursing,Complementary and alternative medicine,Complementary and Manual Therapy

Reference51 articles.

1. Clinical practice: chronic hepatitis C infection;Rosen;N Engl J Med,2011

2. Viral hepatitis infections in southern Taiwan: a multicenter community-based study;Yang;Kaohsiung J Med Sci,2010

3. Update on the management and treatment of hepatitis c virus infection: recommendations from the department of veterans affairs hepatitis C resource center program and the national hepatitis C program office;Yee;Am J Gastroenterol.,2012

4. Peginterferon and ribavirin for chronic hepatitis C;Hoofnagle;N Engl J Med,2006

5. EASL clinical practice guidelines: management of hepatitis C virus infection;Craxì;J Hepatol,2011

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Licorice and liver function in patients with primary liver disease: A systematic review and meta‐analysis of RCTs;Phytotherapy Research;2024-07-30

2. Integrated serum pharmacochemistry and network pharmacology to explore the mechanism of Yi-Shan-Hong formula in alleviating chronic liver injury;Phytomedicine;2024-06

3. Traditional Chinese medicine Kuan-Sin-Yin decoction inhibits cell mobility via downregulation of CCL2, CEACAM1 and PIK3R3 in hepatocellular carcinoma cells;Journal of Ethnopharmacology;2023-12

4. References and Bibliography;The Greening of Pharmaceutical Engineering Volume 4;2023-02-06

5. The banned herbal medicine induced liver injury in Taiwan;Hepatology International;2022-04-28

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3